Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:LMNL

Liminal BioSciences (LMNL) Stock Price, News & Analysis

Liminal BioSciences logo

About Liminal BioSciences Stock (NASDAQ:LMNL)

Advanced Chart

Key Stats

Today's Range
$8.50
$8.50
50-Day Range
$8.38
$8.50
52-Week Range
$3.10
$8.50
Volume
N/A
Average Volume
63,470 shs
Market Capitalization
$26.35 million
P/E Ratio
29.31
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive LMNL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Liminal BioSciences and its competitors with MarketBeat's FREE daily newsletter.

LMNL Stock News Headlines

Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.
See More Headlines

LMNL Stock Analysis - Frequently Asked Questions

Liminal BioSciences Inc. (NASDAQ:LMNL) issued its quarterly earnings results on Monday, November, 15th. The company reported $27.40 EPS for the quarter, beating analysts' consensus estimates of ($2.80) by $30.20. The company had revenue of $0.14 million for the quarter, compared to analyst estimates of $0.02 million. Liminal BioSciences had a negative trailing twelve-month return on equity of 88.44% and a net margin of 248.35%.

Liminal BioSciences's stock reverse split on the morning of Wednesday, February 1st 2023.The 1-10 reverse split was announced on Wednesday, February 1st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, February 1st 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Liminal BioSciences investors own include Corbus Pharmaceuticals (CRBP), Bionano Genomics (BNGO), HubSpot (HUBS), iBio (IBIO), Dynavax Technologies (DVAX), Diamondback Energy (FANG) and NIO (NIO).

Company Calendar

Last Earnings
11/15/2021
Today
7/31/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:LMNL
CIK
1351172
Employees
251
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$0.29
Trailing P/E Ratio
29.31
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$380 thousand
Net Margins
248.35%
Pretax Margin
-5,729.40%
Return on Equity
-88.44%
Return on Assets
-64.15%

Debt

Debt-to-Equity Ratio
0.02
Current Ratio
2.78
Quick Ratio
2.78

Sales & Book Value

Annual Sales
$310 thousand
Price / Sales
85.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$8.97 per share
Price / Book
0.95

Miscellaneous

Outstanding Shares
3,100,000
Free Float
3,036,000
Market Cap
$26.35 million
Optionable
Not Optionable
Beta
1.03

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:LMNL) was last updated on 7/31/2025 by MarketBeat.com Staff
From Our Partners